US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lyell Immunopharma, Inc.

11.02

-0.7900-6.69%

Post-market: 11.020.00000.00%16:33 EDT

Volume:19.79K

Turnover:222.92K

Market Cap:170.34M

PE:-0.45

High:11.67

Open:11.57

Low:11.02

Close:11.81

Loading ...

Overview Company News Filings

Lyell Immunopharma Inc. Files Initial Statement of Beneficial Ownership for ARCH Venture Fund XIII, L.P

Lyell Immunopharma Initiates Phase 3 Clinical Trial for LYL314 in Relapsed or Refractory Large B-Cell Lymphoma

Lyell Immunopharma Announces Up to $100 Million Equity Private Placement to Fund Clinical Trials and Corporate Initiatives

Lyell Immunopharma Announces up to $100 Million Equity Private Placement

THOMSON REUTERS

Lyell Immunopharma Inc - Proceeds to Fund Two Pivotal-Stage Trials of Lyl314

THOMSON REUTERS

Lyell Immunopharma files to sell 625,000 shares of common stock for holders

Lyell Immunopharma Inc. Completes Issuance of 625,000 Equity Milestone Shares Following ImmPACT Acquisition

Lyell Immunopharma Is Maintained at Neutral by HC Wainwright & Co.

Lyell Immunopharma Inc. to Participate in H.C. Wainwright "HCW@Home" Series for Discussion on Innovative CAR T-Cell Therapies

Morgan Stanley Sticks to Its Hold Rating for Lyell Immunopharma (LYEL)

BUZZ-U.S. STOCKS ON THE MOVE-Red Cat, Nvidia Corp, Redwire

BUZZ-U.S. STOCKS ON THE MOVE-Verve Therapeutics, Lyell Immunopharma, Energy companies

BUZZ-Lyell Immunopharma rises on promising data from blood cancer therapy study

Lyell Immunopharma Announces Promising Phase 1/2 Trial Results for LYL314 in Treating Aggressive Large B-cell Lymphoma, Launches Pivotal PiNACLE Trial

Lyell Immunopharma Inc. Files Initial Beneficial Ownership Statement for General Counsel Mark Meltz

Lyell Immunopharma Expands Board, Appoints New Director

Lyell Immunopharma Inc. Enhances Leadership Team with Key Board and Executive Appointments to Advance Cancer Therapies

BRIEF-Lyell Immunopharma Strengthens Clinical And Commercial Capabilities With Key Board And Executive Appointments

Lyell Immunopharma trading resumes

Lyell Immunopharma trading halted, news pending

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LYEL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LYEL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LYEL\",,,,,undefined,":{"symbol":"LYEL","market":"US","secType":"STK","nameCN":"Lyell Immunopharma, Inc.","latestPrice":11.02,"timestamp":1754078400000,"preClose":11.81,"halted":0,"volume":19786,"hourTrading":{"tag":"盘后","latestPrice":11.02,"preClose":11.02,"latestTime":"16:33 EDT","volume":154,"amount":1697.3,"timestamp":1754080428763},"delay":0,"floatShares":10620934,"shares":15457400,"eps":-24.625135,"marketStatus":"Market Closed","change":-0.79,"latestTime":"08-01 16:00:00 EDT","open":11.57,"high":11.665,"low":11.02,"amount":222915.439,"amplitude":0.054615,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-24.625135,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754294400000},"marketStatusCode":7,"adr":0,"listingDate":1623902400000,"exchange":"NASDAQ","adjPreClose":11.81,"preHourTrading":{"tag":"盘前","latestPrice":11.81,"preClose":11.81,"latestTime":"08:00 EDT","volume":1,"amount":11.81,"timestamp":1754049600789},"postHourTrading":{"tag":"盘后","latestPrice":11.02,"preClose":11.02,"latestTime":"16:33 EDT","volume":154,"amount":1697.3,"timestamp":1754080428763},"volumeRatio":0.10852574564381262,"impliedVol":1.2021,"impliedVolPercentile":0.4578},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LYEL\",,,,,undefined,":{"symbol":"LYEL","floatShares":10620934,"roa":"-24.40%","roe":"-71.20%","lyrEps":-26.234817,"volumeRatio":0.10852574564381262,"shares":15457400,"dividePrice":0,"high":11.665,"amplitude":0.054615,"preClose":11.81,"low":11.02,"week52Low":7.65,"pbRate":"0.51","psRate":"2620.62","week52High":32.4,"institutionHeld":0,"latestPrice":11.02,"eps":-24.625135,"divideRate":0,"volume":19786,"delay":0,"ttmEps":-24.625135,"open":11.57,"prevYearClose":12.8,"prevWeekClose":12.42,"prevMonthClose":11.81,"prevQuarterClose":8.84,"fiveDayClose":12.42,"twentyDayClose":9.69,"sixtyDayClose":8.314},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LYEL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2555098414","title":"Lyell Immunopharma Inc. Files Initial Statement of Beneficial Ownership for ARCH Venture Fund XIII, L.P","url":"https://stock-news.laohu8.com/highlight/detail?id=2555098414","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555098414?lang=en_us&edition=fundamental","pubTime":"2025-07-30 09:24","pubTimestamp":1753838682,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma Inc. has filed an initial statement of beneficial ownership, identifying ARCH Venture Fund XIII, L.P. as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lyell Immunopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 29, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250730:nNDL17rRbm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","LYEL","BK4505"],"gpt_icon":0},{"id":"2554762291","title":"Lyell Immunopharma Initiates Phase 3 Clinical Trial for LYL314 in Relapsed or Refractory Large B-Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2554762291","media":"Reuters","labels":["shareholding","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554762291?lang=en_us&edition=fundamental","pubTime":"2025-07-25 20:06","pubTimestamp":1753445192,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma, Inc. has announced the initiation of two pivotal-stage clinical trials for its product candidate LYL314. The trials will focus on patients with large B-cell lymphoma  who have relapsed or are refractory to two or more lines of prior therapy. The company plans to submit a Biologics License Application for LYL314 later in 2027, following the expected data from the LYL314 PiNACLE pivotal trial. Additionally, Lyell is set to conduct a Phase 3 randomized controlled trial for LYL314 in the second-line setting for relapsed or refractory LBCL patients. Furthermore, the company intends to begin a clinical trial evaluating a new internally-developed CAR T-cell therapy targeting an undisclosed solid tumor. Results from these trials are anticipated in the future, with a clinical trial data update from LYL314 expected by the end of this year.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250725:nNDL8lHkc7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","LYEL","BK4505"],"gpt_icon":0},{"id":"2554762950","title":"Lyell Immunopharma Announces Up to $100 Million Equity Private Placement to Fund Clinical Trials and Corporate Initiatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2554762950","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554762950?lang=en_us&edition=fundamental","pubTime":"2025-07-25 20:00","pubTimestamp":1753444820,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma Inc., a clinical-stage company focused on advancing next-generation CAR T-cell therapies for cancer treatment, announced a securities purchase agreement for a private placement with institutional and accredited investors, potentially raising up to $100 million. The initial closing is expected to yield approximately $50 million from the sale of common stock at $13.32 per share. The funds will support pivotal-stage clinical trials of LYL314 and other corporate purposes, with expectations to sustain financial needs into mid-2027. This includes funding through significant milestones such as a clinical trial data update from LYL314, the initiation of a Phase 3 trial for relapsed or refractory large B-cell lymphoma, and a trial for a new CAR T-cell therapy targeting an undisclosed solid tumor. Investors are provided with resale registration rights for the common stock shares issued in this financing.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250725:nNDL9klSct:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4505","IE00B3QW5Z07.USD","LU2210149790.SGD","NDAQ","BK4588","BK4585","LU2095319765.USD","IE00BGHQF748.EUR","LYEL","BK4539","IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4139","LU2210150020.SGD"],"gpt_icon":0},{"id":"2554623987","title":"Lyell Immunopharma Announces up to $100 Million Equity Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2554623987","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554623987?lang=en_us&edition=fundamental","pubTime":"2025-07-25 20:00","pubTimestamp":1753444800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250725:nTUA8YVSRV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","LYEL","BK4139","BK4539"],"gpt_icon":0},{"id":"2554611762","title":"Lyell Immunopharma Inc - Proceeds to Fund Two Pivotal-Stage Trials of Lyl314","url":"https://stock-news.laohu8.com/highlight/detail?id=2554611762","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554611762?lang=en_us&edition=fundamental","pubTime":"2025-07-25 20:00","pubTimestamp":1753444800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250725:nTUA8YVSRV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LYEL","BK4505","BK4539"],"gpt_icon":0},{"id":"2552406415","title":"Lyell Immunopharma files to sell 625,000 shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2552406415","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552406415?lang=en_us&edition=fundamental","pubTime":"2025-07-19 10:25","pubTimestamp":1752891953,"startTime":"0","endTime":"0","summary":"22:21 EDT Lyell Immunopharma (LYEL) files to sell 625,000 shares of common stock for holders Published first on TheFly – the ultimate source for re...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lyell-immunopharma-files-to-sell-625000-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lyell-immunopharma-files-to-sell-625000-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","LYEL","BK4505"],"gpt_icon":0},{"id":"2546759304","title":"Lyell Immunopharma Inc. Completes Issuance of 625,000 Equity Milestone Shares Following ImmPACT Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2546759304","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546759304?lang=en_us&edition=fundamental","pubTime":"2025-06-27 04:07","pubTimestamp":1750968467,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma Inc. has issued 625,000 shares of its common stock to the securityholders of ImmPACT Bio USA Inc. following the achievement of certain clinical milestones. The transaction was conducted under a private placement and was exempt from registration under the Securities Act. The document does not provide the price of these shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lyell Immunopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 26, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nNDL5N4KwK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","LYEL","BK4539"],"gpt_icon":0},{"id":"2545289781","title":"Lyell Immunopharma Is Maintained at Neutral by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2545289781","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545289781?lang=en_us&edition=fundamental","pubTime":"2025-06-24 19:12","pubTimestamp":1750763520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LYEL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 24, 2025 07:12 ET (11:12 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYEL"],"gpt_icon":0},{"id":"2545440287","title":"Lyell Immunopharma Inc. to Participate in H.C. Wainwright \"HCW@Home\" Series for Discussion on Innovative CAR T-Cell Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2545440287","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545440287?lang=en_us&edition=fundamental","pubTime":"2025-06-24 05:00","pubTimestamp":1750712418,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma Inc. to Participate in H.C. Wainwright \"HCW@Home\" Series for Discussion on Innovative CAR T-Cell Therapies. Lyell Immunopharma, Inc., a clinical-stage company focused on advancing CAR T-cell therapies for cancer treatment, will participate in the H.C. Wainwright \"HCW@Home\" Series on June 25, 2025. During the event, Lyell's senior management, including President and CEO Lynn Seely and CFO Charlie Newton, will discuss positive new clinical data on LYL314, a dual-targeting CAR T-cell product candidate for large B-cell lymphoma.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lyell Immunopharma Inc. published the original content used to generate this news brief via GlobeNewswire  on June 23, 2025, and is solely responsib","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250623:nNDL2BmbPj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","IE00B3QW5Z07.USD","BK4139","LU2210150020.SGD","NDAQ","IE00BKPKM429.USD","IE00BGHQF748.EUR","LYEL","IE00B64PRP62.GBP","BK4112","BK4585","LU2210149790.SGD","LU2095319765.USD","BK4588","BK4539"],"gpt_icon":0},{"id":"2545172388","title":"Morgan Stanley Sticks to Its Hold Rating for Lyell Immunopharma (LYEL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2545172388","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545172388?lang=en_us&edition=fundamental","pubTime":"2025-06-21 01:45","pubTimestamp":1750441559,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Lyell Immunopharma (LYEL – Research Report) on June 16. The company’s shares open...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-its-hold-rating-for-lyell-immunopharma-lyel-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-its-hold-rating-for-lyell-immunopharma-lyel-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LYEL"],"gpt_icon":0},{"id":"2544199908","title":"BUZZ-U.S. STOCKS ON THE MOVE-Red Cat, Nvidia Corp, Redwire","url":"https://stock-news.laohu8.com/highlight/detail?id=2544199908","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544199908?lang=en_us&edition=fundamental","pubTime":"2025-06-18 00:02","pubTimestamp":1750176150,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Red Cat, Nvidia Corp, RedwireEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: http","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nL6N3SK0RJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVDS.UK","RCAT","WMB","EOG","FDX","TMUS","JBLU","LEN","RUN","VERV","NVDX","LU1951200564.SGD","NVAX","FVR","IE00BKPKM429.USD","CTRI","EQT","SNVD.UK","SHLS","NVDD","JBL","WLY","LNG","3NVD.UK","GALT","LU1037948541.HKD","NVDU","ARRY","NVD2.UK","DVN","NVD3.UK","2NVD.UK","DYN","NVIW.SI","ET","MMYT","NVDY","NVD","LYEL","NVDS","NVDA","CVX","SGRY","LU0130102774.USD","LU2347655156.SGD","RDW"],"gpt_icon":1},{"id":"2544648779","title":"BUZZ-U.S. STOCKS ON THE MOVE-Verve Therapeutics, Lyell Immunopharma, Energy companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2544648779","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544648779?lang=en_us&edition=fundamental","pubTime":"2025-06-17 19:38","pubTimestamp":1750160338,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Verve Therapeutics, Lyell Immunopharma, Energy companiesEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nL6N3SK0KA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2098885051.SGD","IE00B1XK9C88.USD","LU2361044949.HKD","LU2272731782.SGD","LYEL","IE00BGHQF524.EUR","LU0942090050.USD","LU0122376428.USD","SHLS","BK4533","LU1582986359.USD","SG9999014567.USD","BK4570","CVX","ARRY","LU0868494617.USD","LU0070302665.USD","LU0098860793.USD","TMUS","SG9999001440.SGD","LU0234572021.USD","LU0345780950.USD","LU0792757196.USD","LU0128525929.USD","LU2592432038.USD","SG9999002521.SGD","LU2361044865.SGD","LU2264538146.SGD","LU0456854461.SGD","LU1074936037.SGD","LU1621768115.EUR","RUN","LU0310800379.SGD","DVN","FSLR","LU0312595415.SGD","LU2125154778.USD","LU2237438978.USD","LU0985489474.SGD","LU0154245756.USD","LU0889566641.SGD","BK4516","LU0823414478.USD","LU1066051498.USD","LU1983260115.SGD","VERV","LU1582987324.SGD","LU1150488218.USD"],"gpt_icon":1},{"id":"2544796928","title":"BUZZ-Lyell Immunopharma rises on promising data from blood cancer therapy study","url":"https://stock-news.laohu8.com/highlight/detail?id=2544796928","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544796928?lang=en_us&edition=fundamental","pubTime":"2025-06-17 19:00","pubTimestamp":1750158020,"startTime":"0","endTime":"0","summary":"BUZZ-Lyell Immunopharma rises on promising data from blood cancer therapy study** Shares of Lyell Immunopharma LYEL.O rise 15% to $11.70 premarket** Co says 88% of patients with a type of blood cancer who were given LYEL's experimental cell therapy, called LYL314, had their tumors shrink or disappear after treatment in an early- to mid-stage trial** LYEL says 72% of patients experienced a complete disappearance of all signs of their cancer following treatment with the therapy** Up to last close, stock had fallen 21% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nL6N3SK0JH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","LYEL","BK4505"],"gpt_icon":0},{"id":"2544096690","title":"Lyell Immunopharma Announces Promising Phase 1/2 Trial Results for LYL314 in Treating Aggressive Large B-cell Lymphoma, Launches Pivotal PiNACLE Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2544096690","media":"Reuters","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544096690?lang=en_us&edition=fundamental","pubTime":"2025-06-17 18:30","pubTimestamp":1750156225,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma Announces Promising Phase 1/2 Trial Results for LYL314 in Treating Aggressive Large B-cell Lymphoma, Launches Pivotal PiNACLE Trial. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lyell Immunopharma Inc. published the original content used to generate this news brief via GlobeNewswire  on June 17, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nNDL5X0lJP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","BK4505","BK4588","BK4585","LYEL","LU2095319765.USD","IE00B3QW5Z07.USD","BK4539","LU2210150020.SGD","BK4139","IE00BGHQF748.EUR","BK4112","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2542583215","title":"Lyell Immunopharma Inc. Files Initial Beneficial Ownership Statement for General Counsel Mark Meltz","url":"https://stock-news.laohu8.com/highlight/detail?id=2542583215","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542583215?lang=en_us&edition=fundamental","pubTime":"2025-06-12 05:41","pubTimestamp":1749678085,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma Inc. has filed an initial statement of beneficial ownership with the United States Securities and Exchange Commission. The filing lists Mark A. Meltz as the beneficial owner, serving in the role of General Counsel. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lyell Immunopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 11, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nNDL612gNl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYEL","BK4139","BK4505","BK4539"],"gpt_icon":0},{"id":"2542081330","title":"Lyell Immunopharma Expands Board, Appoints New Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2542081330","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542081330?lang=en_us&edition=fundamental","pubTime":"2025-06-10 04:49","pubTimestamp":1749502168,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma ( ($LYEL) ) just unveiled an announcement. On June 9, 2025, Lyell Immunopharma‘s Board of Directors expanded from seven to eight...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lyell-immunopharma-expands-board-appoints-new-director?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lyell-immunopharma-expands-board-appoints-new-director?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","BK4139","BK4539","LYEL"],"gpt_icon":0},{"id":"2542337629","title":"Lyell Immunopharma Inc. Enhances Leadership Team with Key Board and Executive Appointments to Advance Cancer Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2542337629","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542337629?lang=en_us&edition=fundamental","pubTime":"2025-06-10 04:05","pubTimestamp":1749499541,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma Inc., a clinical-stage company focused on CAR T-cell therapies, has announced new management appointments to strengthen its clinical and commercial capabilities. Mark J. Bachleda, PharmD, MBA, has been appointed as an independent member of the Board of Directors. Additionally, David Shook, MD, has been named Chief Medical Officer, Mark Meltz, JD, as General Counsel and Corporate Secretary, and Jarrad Aguirre, MD, MBA, as Senior Vice-President of Medical Affairs. These changes come as Lyell advances its programs for LYL314, targeting aggressive large B-cell lymphoma.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lyell Immunopharma Inc. published the original content used to generate this news brief via GlobeNewswire ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nNDLdbjhq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","IE00BGHQF748.EUR","LU2095319765.USD","LYEL","BK4139","IE00BKPKM429.USD","NDAQ","LU2210150020.SGD","BK4505","IE00B3QW5Z07.USD","BK4539","LU2210149790.SGD","BK4112","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2542337627","title":"BRIEF-Lyell Immunopharma Strengthens Clinical And Commercial Capabilities With Key Board And Executive Appointments","url":"https://stock-news.laohu8.com/highlight/detail?id=2542337627","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542337627?lang=en_us&edition=fundamental","pubTime":"2025-06-10 04:05","pubTimestamp":1749499541,"startTime":"0","endTime":"0","summary":"BRIEF-Lyell Immunopharma Strengthens Clinical And Commercial Capabilities With Key Board And Executive AppointmentsLyell Immunopharma Inc LYEL.O:LYELL IMMUNOPHARMA STRENGTHENS CLINICAL AND COMMERCIAL ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nTUABVJY25:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LYEL","BK4505","BK4539"],"gpt_icon":0},{"id":"2540796612","title":"Lyell Immunopharma trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2540796612","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540796612?lang=en_us&edition=fundamental","pubTime":"2025-06-02 21:45","pubTimestamp":1748871939,"startTime":"0","endTime":"0","summary":"09:43 EDT Lyell Immunopharma (LYEL) trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lyell-immunopharma-trading-resumes-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lyell-immunopharma-trading-resumes-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","BK4139","BK4539","LYEL"],"gpt_icon":0},{"id":"2539206605","title":"Lyell Immunopharma trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2539206605","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539206605?lang=en_us&edition=fundamental","pubTime":"2025-05-31 07:50","pubTimestamp":1748649022,"startTime":"0","endTime":"0","summary":"19:50 EDT Lyell Immunopharma (LYEL) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving break...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lyell-immunopharma-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lyell-immunopharma-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LYEL","BK4505","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":43,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LYEL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-06-02","symbol":"LYEL","defaultRemindTime":1748871000000,"type":"split","dateTimestamp":1748836800000,"forFactor":20,"toFactor":1,"ratio":20},{"market":"US","date":"2025-05-13","symbol":"LYEL","fiscalQuarterEnding":"2025/03","expectedEps":-0.19,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2021-08-12","symbol":"LYEL","fiscalQuarterEnding":"2021/06","expectedEps":-1.54,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-1.25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LYEL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LYEL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":0.5,"sell":0.5,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.5,"analysts":2,"updateTime":1730347200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LYEL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LYEL","date":"2025-08-01","current":-0.523591,"percent":0.911794,"low":-22.356321,"twenty":-7.306207,"median":-3.009843,"eighty":-1.505683,"high":-0.344317,"avg":-4.904302,"sd":4.83952,"marketCap":175152551},"quantilePoints":[{"date":"2021-06-18","current":-16.694562,"twenty":-17.926867,"median":-17.666247,"eighty":-17.121201,"marketCap":3844340254},{"date":"2021-06-25","current":-16.478151,"twenty":-17.614123,"median":-17.106773,"eighty":-16.61212,"marketCap":3794506214},{"date":"2021-07-02","current":-16.519372,"twenty":-17.263414,"median":-16.936736,"eighty":-16.511128,"marketCap":3803998412},{"date":"2021-07-09","current":-16.364793,"twenty":-17.143872,"median":-16.715173,"eighty":-16.410136,"marketCap":3768402669},{"date":"2021-07-16","current":-17.426237,"twenty":-17.174788,"median":-16.735783,"eighty":-16.482273,"marketCap":4012826772},{"date":"2021-07-23","current":-14.870526,"twenty":-17.174788,"median":-16.725478,"eighty":-16.253496,"marketCap":3424310486},{"date":"2021-07-30","current":-14.942663,"twenty":-17.143872,"median":-16.560593,"eighty":-15.769148,"marketCap":3440921833},{"date":"2021-08-06","current":-16.117466,"twenty":-17.090285,"median":-16.509067,"eighty":-15.769148,"marketCap":3711449480},{"date":"2021-08-13","current":-18.445521,"twenty":-17.143872,"median":-16.498762,"eighty":-15.358997,"marketCap":3545487430},{"date":"2021-08-20","current":-18.856529,"twenty":-17.417993,"median":-16.627578,"eighty":-15.57953,"marketCap":3624488838},{"date":"2021-08-27","current":-20.214099,"twenty":-17.926867,"median":-16.735783,"eighty":-15.769148,"marketCap":3885432883},{"date":"2021-09-03","current":-20.525469,"twenty":-18.490358,"median":-16.802768,"eighty":-15.903116,"marketCap":3945282434},{"date":"2021-09-10","current":-22.356321,"twenty":-19.232663,"median":-17.003721,"eighty":-15.991741,"marketCap":4297197797},{"date":"2021-09-17","current":-14.709089,"twenty":-19.232663,"median":-16.952194,"eighty":-15.876323,"marketCap":2827292812},{"date":"2021-09-24","current":-15.294463,"twenty":-19.005986,"median":-16.777005,"eighty":-15.276839,"marketCap":2939809969},{"date":"2021-10-01","current":-16.552396,"twenty":-18.789273,"median":-16.78731,"eighty":-15.333339,"marketCap":3181602157},{"date":"2021-10-08","current":-16.116478,"twenty":-18.505304,"median":-16.725478,"eighty":-15.276839,"marketCap":3097812785},{"date":"2021-10-15","current":-16.539941,"twenty":-18.44303,"median":-16.694562,"eighty":-15.276839,"marketCap":3179208175},{"date":"2021-10-22","current":-17.175134,"twenty":-18.41563,"median":-16.725478,"eighty":-15.333339,"marketCap":3301301260},{"date":"2021-10-29","current":-17.361956,"twenty":-18.41563,"median":-16.78731,"eighty":-15.492314,"marketCap":3337210991},{"date":"2021-11-05","current":-17.212499,"twenty":-18.44303,"median":-16.889297,"eighty":-15.548067,"marketCap":3308483206},{"date":"2021-11-12","current":-13.33676,"twenty":-18.41563,"median":-16.78731,"eighty":-15.276839,"marketCap":2738970350},{"date":"2021-11-19","current":-12.657627,"twenty":-18.330937,"median":-16.725478,"eighty":-15.027931,"marketCap":2599496882},{"date":"2021-11-26","current":-10.90125,"twenty":-18.271154,"median":-16.627578,"eighty":-14.942663,"marketCap":2238789637},{"date":"2021-12-03","current":-10.409464,"twenty":-18.134152,"median":-16.539941,"eighty":-14.709089,"marketCap":2137791608},{"date":"2021-12-10","current":-10.948086,"twenty":-18.109242,"median":-16.493609,"eighty":-14.3479,"marketCap":2248408496},{"date":"2021-12-17","current":-9.765459,"twenty":-18.071878,"median":-16.415393,"eighty":-13.737616,"marketCap":2005532284},{"date":"2021-12-23","current":-9.613239,"twenty":-18.012095,"median":-16.364793,"eighty":-12.985484,"marketCap":1974270990},{"date":"2021-12-31","current":-9.062908,"twenty":-17.940923,"median":-16.245376,"eighty":-12.198627,"marketCap":1861249386},{"date":"2022-01-07","current":-7.470459,"twenty":-17.926867,"median":-16.141388,"eighty":-11.395378,"marketCap":1534208150},{"date":"2022-01-14","current":-7.072347,"twenty":-17.903382,"median":-16.080903,"eighty":-10.997265,"marketCap":1452447841},{"date":"2022-01-21","current":-6.123903,"twenty":-17.830255,"median":-16.014551,"eighty":-10.929352,"marketCap":1257665929},{"date":"2022-01-28","current":-6.147321,"twenty":-17.680798,"median":-15.983497,"eighty":-10.514847,"marketCap":1262475359},{"date":"2022-02-04","current":-6.627398,"twenty":-17.596106,"median":-15.610877,"eighty":-9.704571,"marketCap":1361068673},{"date":"2022-02-11","current":-7.072347,"twenty":-17.556251,"median":-15.294463,"eighty":-9.011387,"marketCap":1452447841},{"date":"2022-02-18","current":-7.013801,"twenty":-17.470271,"median":-15.182102,"eighty":-8.728025,"marketCap":1440424267},{"date":"2022-02-25","current":-8.102755,"twenty":-17.425434,"median":-15.057823,"eighty":-8.163643,"marketCap":1664062759},{"date":"2022-03-04","current":-7.634387,"twenty":-17.416789,"median":-14.958184,"eighty":-7.964586,"marketCap":1567874160},{"date":"2022-03-11","current":-7.669515,"twenty":-17.388159,"median":-14.860221,"eighty":-7.915408,"marketCap":1575088305},{"date":"2022-03-18","current":-7.013801,"twenty":-17.351992,"median":-14.709089,"eighty":-7.723377,"marketCap":1440424267},{"date":"2022-03-25","current":-5.971683,"twenty":-17.3221,"median":-14.403329,"eighty":-7.58755,"marketCap":1226404634},{"date":"2022-04-01","current":-5.20082,"twenty":-17.2947,"median":-14.061441,"eighty":-7.470459,"marketCap":1301343937},{"date":"2022-04-08","current":-5.288147,"twenty":-17.257336,"median":-13.830028,"eighty":-7.346342,"marketCap":1323194861},{"date":"2022-04-14","current":-5.229929,"twenty":-17.211964,"median":-13.518506,"eighty":-7.16602,"marketCap":1308627578},{"date":"2022-04-22","current":-5.045571,"twenty":-17.203643,"median":-12.938648,"eighty":-7.018485,"marketCap":1262497849},{"date":"2022-04-29","current":-4.97765,"twenty":-17.178155,"median":-12.487844,"eighty":-6.955255,"marketCap":1245502686},{"date":"2022-05-06","current":-5.152305,"twenty":-17.173828,"median":-11.627219,"eighty":-6.641449,"marketCap":1289204534},{"date":"2022-05-13","current":-3.729604,"twenty":-17.156239,"median":-11.381327,"eighty":-6.524357,"marketCap":982079216},{"date":"2022-05-20","current":-3.841772,"twenty":-17.098529,"median":-11.135433,"eighty":-6.360429,"marketCap":1011615433},{"date":"2022-05-27","current":-4.056762,"twenty":-17.063491,"median":-10.953941,"eighty":-6.039597,"marketCap":1068226516},{"date":"2022-06-03","current":-4.711078,"twenty":-17.055247,"median":-10.924668,"eighty":-5.971683,"marketCap":1240521115},{"date":"2022-06-10","current":-4.767162,"twenty":-16.952194,"median":-10.74903,"eighty":-5.501614,"marketCap":1255289224},{"date":"2022-06-17","current":-5.103668,"twenty":-16.826401,"median":-10.444591,"eighty":-5.278444,"marketCap":1343897875},{"date":"2022-06-24","current":-6.225353,"twenty":-16.81986,"median":-9.993788,"eighty":-5.286206,"marketCap":1639260045},{"date":"2022-07-01","current":-5.599079,"twenty":-16.793493,"median":-9.191709,"eighty":-5.303672,"marketCap":1474349500},{"date":"2022-07-08","current":-6.281438,"twenty":-16.774943,"median":-9.016071,"eighty":-5.331041,"marketCap":1654028154},{"date":"2022-07-15","current":-5.514953,"twenty":-16.748149,"median":-8.822869,"eighty":-5.314216,"marketCap":1452197337},{"date":"2022-07-22","current":-5.3467,"twenty":-16.723417,"median":-8.664796,"eighty":-5.314216,"marketCap":1407893012},{"date":"2022-07-29","current":-5.206489,"twenty":-16.702806,"median":-8.301811,"eighty":-5.299791,"marketCap":1370972740},{"date":"2022-08-05","current":-7.600529,"twenty":-16.614181,"median":-8.044209,"eighty":-5.299791,"marketCap":1801690265},{"date":"2022-08-12","current":-7.642348,"twenty":-16.555675,"median":-7.991734,"eighty":-5.314216,"marketCap":1811603279},{"date":"2022-08-19","current":-7.360072,"twenty":-16.544923,"median":-7.950535,"eighty":-5.335483,"marketCap":1744690435},{"date":"2022-08-26","current":-6.575974,"twenty":-16.5276,"median":-7.950535,"eighty":-5.3467,"marketCap":1558821426},{"date":"2022-09-02","current":-7.192798,"twenty":-16.507006,"median":-7.89199,"eighty":-5.375608,"marketCap":1705038380},{"date":"2022-09-09","current":-7.935078,"twenty":-16.49464,"median":-7.88028,"eighty":-5.416736,"marketCap":1880994376},{"date":"2022-09-16","current":-7.516892,"twenty":-16.484334,"median":-7.897852,"eighty":-5.449521,"marketCap":1781864237},{"date":"2022-09-23","current":-6.670066,"twenty":-16.453048,"median":-7.861895,"eighty":-5.45326,"marketCap":1581125707},{"date":"2022-09-30","current":-7.663257,"twenty":-16.400447,"median":-7.848297,"eighty":-5.462607,"marketCap":1816559786},{"date":"2022-10-07","current":-7.391436,"twenty":-16.372735,"median":-7.851441,"eighty":-5.468216,"marketCap":1752125196},{"date":"2022-10-14","current":-6.83734,"twenty":-16.35016,"median":-7.81485,"eighty":-5.468216,"marketCap":1620777762},{"date":"2022-10-21","current":-6.847795,"twenty":-16.313264,"median":-7.751479,"eighty":-5.477563,"marketCap":1623256016},{"date":"2022-10-28","current":-6.38779,"twenty":-16.25447,"median":-7.704859,"eighty":-5.495596,"marketCap":1514212864},{"date":"2022-11-04","current":-5.93824,"twenty":-16.191664,"median":-7.669515,"eighty":-5.50695,"marketCap":1407647965},{"date":"2022-11-11","current":-4.370461,"twenty":-16.164134,"median":-7.652802,"eighty":-5.468216,"marketCap":1129445090},{"date":"2022-11-18","current":-4.235391,"twenty":-16.131819,"median":-7.634387,"eighty":-5.449521,"marketCap":1094539502},{"date":"2022-11-25","current":-4.013492,"twenty":-16.117268,"median":-7.600529,"eighty":-5.3467,"marketCap":1037194608},{"date":"2022-12-02","current":-3.88807,"twenty":-16.102248,"median":-7.558277,"eighty":-5.287232,"marketCap":1004782276},{"date":"2022-12-09","current":-3.38156,"twenty":-16.041207,"median":-7.516892,"eighty":-5.259745,"marketCap":873886322},{"date":"2022-12-16","current":-3.116245,"twenty":-16.020651,"median":-7.489702,"eighty":-5.234588,"marketCap":805321775},{"date":"2022-12-23","current":-2.942584,"twenty":-16.001894,"median":-7.470459,"eighty":-5.20082,"marketCap":760443162},{"date":"2022-12-30","current":-3.347792,"twenty":-15.991931,"median":-7.407118,"eighty":-5.178447,"marketCap":865159925},{"date":"2023-01-06","current":-3.154836,"twenty":-15.985184,"median":-7.391436,"eighty":-5.132899,"marketCap":815294800},{"date":"2023-01-13","current":-3.116245,"twenty":-15.876323,"median":-7.35672,"eighty":-5.045571,"marketCap":805321775},{"date":"2023-01-20","current":-2.884697,"twenty":-15.769148,"median":-7.319501,"eighty":-5.004818,"marketCap":745483624},{"date":"2023-01-27","current":-3.222371,"twenty":-15.58994,"median":-7.255526,"eighty":-4.957491,"marketCap":832747594},{"date":"2023-02-03","current":-3.280258,"twenty":-15.495784,"median":-7.203252,"eighty":-4.852942,"marketCap":847707131},{"date":"2023-02-10","current":-2.759276,"twenty":-15.372215,"median":-7.16602,"eighty":-4.658733,"marketCap":713071293},{"date":"2023-02-17","current":-2.51808,"twenty":-15.281245,"median":-7.127136,"eighty":-4.40097,"marketCap":650739886},{"date":"2023-02-24","current":-2.054985,"twenty":-15.24139,"median":-7.072347,"eighty":-4.297137,"marketCap":531063585},{"date":"2023-03-03","current":-3.026095,"twenty":-15.184647,"median":-7.037219,"eighty":-4.234774,"marketCap":554132528},{"date":"2023-03-10","current":-2.712581,"twenty":-15.144685,"median":-7.009208,"eighty":-4.144702,"marketCap":496722401},{"date":"2023-03-17","current":-2.903416,"twenty":-15.067786,"median":-7.002092,"eighty":-4.0308,"marketCap":531667696},{"date":"2023-03-24","current":-2.739843,"twenty":-15.002478,"median":-6.947944,"eighty":-3.941641,"marketCap":501714586},{"date":"2023-03-31","current":-3.21693,"twenty":-14.979788,"median":-6.847795,"eighty":-3.877116,"marketCap":589077822},{"date":"2023-04-06","current":-3.503182,"twenty":-14.95508,"median":-6.791326,"eighty":-3.841772,"marketCap":641495764},{"date":"2023-04-14","current":-3.775804,"twenty":-14.928236,"median":-6.698816,"eighty":-3.793887,"marketCap":691417614},{"date":"2023-04-21","current":-3.053357,"twenty":-14.866404,"median":-6.650816,"eighty":-3.755799,"marketCap":559124713},{"date":"2023-04-28","current":-2.658057,"twenty":-14.849916,"median":-6.633253,"eighty":-3.642559,"marketCap":486738031},{"date":"2023-05-05","current":-3.298717,"twenty":-14.821751,"median":-6.575974,"eighty":-3.508635,"marketCap":604054377},{"date":"2023-05-12","current":-3.457401,"twenty":-14.671725,"median":-6.54314,"eighty":-3.473214,"marketCap":629015302},{"date":"2023-05-19","current":-3.457401,"twenty":-14.499848,"median":-6.38779,"eighty":-3.464474,"marketCap":629015302},{"date":"2023-05-26","current":-3.896436,"twenty":-14.407436,"median":-6.36768,"eighty":-3.473214,"marketCap":708890261},{"date":"2023-06-02","current":-4.568708,"twenty":-14.396483,"median":-6.357152,"eighty":-3.473214,"marketCap":831198792},{"date":"2023-06-09","current":-4.225712,"twenty":-14.3479,"median":-6.281438,"eighty":-3.503182,"marketCap":768796480},{"date":"2023-06-16","current":-5.29586,"twenty":-14.061441,"median":-6.257519,"eighty":-3.503182,"marketCap":963491693},{"date":"2023-06-23","current":-4.513829,"twenty":-14.001658,"median":-6.228162,"eighty":-3.524992,"marketCap":821214422},{"date":"2023-06-30","current":-4.294311,"twenty":-13.948149,"median":-6.173469,"eighty":-3.546802,"marketCap":781276943},{"date":"2023-07-07","current":-3.930735,"twenty":-13.84851,"median":-6.1421,"eighty":-3.566976,"marketCap":715130492},{"date":"2023-07-14","current":-4.294311,"twenty":-13.72267,"median":-6.113185,"eighty":-3.59924,"marketCap":781276943},{"date":"2023-07-21","current":-4.253152,"twenty":-13.554855,"median":-6.089817,"eighty":-3.631866,"marketCap":773788665},{"date":"2023-07-27","current":-4.253152,"twenty":-13.33676,"median":-6.029058,"eighty":-3.639493,"marketCap":773788665},{"date":"2023-08-03","current":-3.622039,"twenty":-13.065106,"median":-5.995102,"eighty":-3.636951,"marketCap":658968412},{"date":"2023-08-11","current":-2.767887,"twenty":-12.950357,"median":-5.958308,"eighty":-3.576245,"marketCap":579872363},{"date":"2023-08-18","current":-2.684012,"twenty":-12.835607,"median":-5.924847,"eighty":-3.497188,"marketCap":562300473},{"date":"2023-08-25","current":-2.67203,"twenty":-12.688071,"median":-5.837903,"eighty":-3.457401,"marketCap":559790203},{"date":"2023-09-01","current":-2.863745,"twenty":-12.385974,"median":-5.708238,"eighty":-3.438793,"marketCap":599954522},{"date":"2023-09-08","current":-2.34851,"twenty":-11.95976,"median":-5.599079,"eighty":-3.385905,"marketCap":492012914},{"date":"2023-09-15","current":-2.090893,"twenty":-11.683423,"median":-5.5243,"eighty":-3.342883,"marketCap":438042109},{"date":"2023-09-22","current":-1.773365,"twenty":-11.566331,"median":-5.496599,"eighty":-3.255097,"marketCap":371519955},{"date":"2023-09-29","current":-1.881205,"twenty":-11.446898,"median":-5.468216,"eighty":-3.219106,"marketCap":394112385},{"date":"2023-10-06","current":-1.785347,"twenty":-11.38601,"median":-5.454194,"eighty":-3.197376,"marketCap":374030225},{"date":"2023-10-13","current":-1.869223,"twenty":-11.287653,"median":-5.39488,"eighty":-3.168343,"marketCap":391602115},{"date":"2023-10-20","current":-1.893187,"twenty":-11.163535,"median":-5.332679,"eighty":-3.158301,"marketCap":396622655},{"date":"2023-10-27","current":-1.953098,"twenty":-11.1448,"median":-5.313106,"eighty":-3.154836,"marketCap":409174005},{"date":"2023-11-03","current":-2.396439,"twenty":-11.032392,"median":-5.288147,"eighty":-3.144199,"marketCap":502053994},{"date":"2023-11-10","current":-2.901609,"twenty":-10.969163,"median":-5.278444,"eighty":-3.116245,"marketCap":551593039},{"date":"2023-11-17","current":-2.47763,"twenty":-10.950428,"median":-5.259038,"eighty":-3.07552,"marketCap":470994970},{"date":"2023-11-24","current":-2.225892,"twenty":-10.948086,"median":-5.259038,"eighty":-3.034274,"marketCap":423139866},{"date":"2023-12-01","current":-2.292139,"twenty":-10.919984,"median":-5.220226,"eighty":-2.985202,"marketCap":435733314},{"date":"2023-12-08","current":-2.570375,"twenty":-10.859097,"median":-5.20082,"eighty":-2.966092,"marketCap":488625797},{"date":"2023-12-15","current":-2.67637,"twenty":-10.781816,"median":-5.191971,"eighty":-2.932936,"marketCap":508775315},{"date":"2023-12-22","current":-2.649872,"twenty":-10.622571,"median":-5.162008,"eighty":-2.925226,"marketCap":503737936},{"date":"2023-12-29","current":-2.795615,"twenty":-10.526556,"median":-5.142602,"eighty":-2.903531,"marketCap":531443522},{"date":"2024-01-05","current":-2.636622,"twenty":-10.491428,"median":-5.132899,"eighty":-2.892415,"marketCap":501219246},{"date":"2024-01-12","current":-2.914859,"twenty":-10.423515,"median":-5.074619,"eighty":-2.876069,"marketCap":554111729},{"date":"2024-01-19","current":-2.610123,"twenty":-10.297056,"median":-5.040719,"eighty":-2.870527,"marketCap":496181866},{"date":"2024-01-26","current":-2.769116,"twenty":-9.948122,"median":-4.987353,"eighty":-2.82681,"marketCap":526406143},{"date":"2024-02-02","current":-2.451131,"twenty":-9.674127,"median":-4.970553,"eighty":-2.813035,"marketCap":465957590},{"date":"2024-02-09","current":-2.26564,"twenty":-9.360321,"median":-4.907373,"eighty":-2.806332,"marketCap":430695935},{"date":"2024-02-16","current":-2.517378,"twenty":-9.114428,"median":-4.849986,"eighty":-2.790315,"marketCap":478551039},{"date":"2024-02-23","current":-3.232843,"twenty":-9.044173,"median":-4.776239,"eighty":-2.787665,"marketCap":614560281},{"date":"2024-03-01","current":-3.162234,"twenty":-9.011387,"median":-4.733346,"eighty":-2.795615,"marketCap":741961228},{"date":"2024-03-08","current":-2.729051,"twenty":-8.93879,"median":-4.699047,"eighty":-2.787665,"marketCap":640322703},{"date":"2024-03-15","current":-2.393334,"twenty":-8.826382,"median":-4.580215,"eighty":-2.779437,"marketCap":561552847},{"date":"2024-03-22","current":-2.209232,"twenty":-8.791255,"median":-4.524152,"eighty":-2.767887,"marketCap":518356474},{"date":"2024-03-28","current":-2.209232,"twenty":-8.749102,"median":-4.472669,"eighty":-2.760842,"marketCap":518356474},{"date":"2024-04-05","current":-2.26338,"twenty":-8.661036,"median":-4.437996,"eighty":-2.746312,"marketCap":531061289},{"date":"2024-04-12","current":-2.880665,"twenty":-8.612285,"median":-4.40407,"eighty":-2.740398,"marketCap":675896187},{"date":"2024-04-19","current":-2.523289,"twenty":-8.473521,"median":-4.37663,"eighty":-2.729051,"marketCap":592044404},{"date":"2024-04-26","current":-2.390385,"twenty":-8.435978,"median":-4.373545,"eighty":-2.713288,"marketCap":560860924},{"date":"2024-05-03","current":-2.607693,"twenty":-8.343298,"median":-4.308031,"eighty":-2.687454,"marketCap":611848281},{"date":"2024-05-10","current":-2.992192,"twenty":-8.3219,"median":-4.294311,"eighty":-2.687454,"marketCap":683237114},{"date":"2024-05-17","current":-3.103841,"twenty":-8.319809,"median":-4.254687,"eighty":-2.687454,"marketCap":708731037},{"date":"2024-05-24","current":-3.025687,"twenty":-8.307263,"median":-4.253152,"eighty":-2.697369,"marketCap":690885291},{"date":"2024-05-31","current":-2.969862,"twenty":-8.290536,"median":-4.253152,"eighty":-2.702869,"marketCap":678138330},{"date":"2024-06-07","current":-2.768894,"twenty":-8.254974,"median":-4.239432,"eighty":-2.702869,"marketCap":632249270},{"date":"2024-06-14","current":-2.891708,"twenty":-8.249968,"median":-4.234362,"eighty":-2.702869,"marketCap":660292584},{"date":"2024-06-21","current":-2.322298,"twenty":-8.16114,"median":-4.225712,"eighty":-2.684796,"marketCap":530273581},{"date":"2024-06-28","current":-1.540756,"twenty":-8.102755,"median":-4.225015,"eighty":-2.684012,"marketCap":351816126},{"date":"2024-07-05","current":-1.685899,"twenty":-8.085705,"median":-4.184553,"eighty":-2.678934,"marketCap":384958225},{"date":"2024-07-12","current":-1.898032,"twenty":-8.051656,"median":-4.129469,"eighty":-2.657094,"marketCap":433396677},{"date":"2024-07-15","current":-1.909197,"twenty":-8.044209,"median":-4.129265,"eighty":-2.653244,"marketCap":435946069},{"date":"2024-08-02","current":-1.674734,"twenty":-8.037183,"median":-4.122609,"eighty":-2.651573,"marketCap":382408833},{"date":"2024-08-09","current":-1.826341,"twenty":-8.006826,"median":-4.102234,"eighty":-2.638911,"marketCap":384004669},{"date":"2024-08-16","current":-1.528039,"twenty":-7.995377,"median":-4.066555,"eighty":-2.636083,"marketCap":321283906},{"date":"2024-08-23","current":-1.765463,"twenty":-7.98391,"median":-4.033634,"eighty":-2.631614,"marketCap":371204513},{"date":"2024-08-30","current":-1.777639,"twenty":-7.976897,"median":-4.016703,"eighty":-2.61181,"marketCap":373764544},{"date":"2024-09-06","current":-1.558478,"twenty":-7.976897,"median":-3.997437,"eighty":-2.600136,"marketCap":327683984},{"date":"2024-09-13","current":-1.400195,"twenty":-7.950535,"median":-3.965035,"eighty":-2.577437,"marketCap":294403579},{"date":"2024-09-20","current":-1.899395,"twenty":-7.950535,"median":-3.965035,"eighty":-2.570375,"marketCap":399364856},{"date":"2024-09-27","current":-1.850692,"twenty":-7.950535,"median":-3.930735,"eighty":-2.557126,"marketCap":389124731},{"date":"2024-10-04","current":-1.448897,"twenty":-7.935078,"median":-3.892473,"eighty":-2.543877,"marketCap":304643704},{"date":"2024-10-11","current":-1.327141,"twenty":-7.903714,"median":-3.88807,"eighty":-2.530627,"marketCap":279043393},{"date":"2024-10-18","current":-1.436722,"twenty":-7.89199,"median":-3.841772,"eighty":-2.517378,"marketCap":302083673},{"date":"2024-10-25","current":-1.327141,"twenty":-7.88028,"median":-3.830328,"eighty":-2.499039,"marketCap":279043393},{"date":"2024-10-31","current":-1.045032,"twenty":-7.865572,"median":-3.823077,"eighty":-2.47498,"marketCap":219727471},{"date":"2024-11-08","current":-1.531082,"twenty":-7.853532,"median":-3.797329,"eighty":-2.424262,"marketCap":312323797},{"date":"2024-11-15","current":-1.505683,"twenty":-7.846411,"median":-3.786677,"eighty":-2.411954,"marketCap":307142675},{"date":"2024-11-22","current":-1.254644,"twenty":-7.841819,"median":-3.775936,"eighty":-2.392744,"marketCap":255933614},{"date":"2024-11-29","current":-1.293655,"twenty":-7.809622,"median":-3.759997,"eighty":-2.378477,"marketCap":263891402},{"date":"2024-12-06","current":-1.259298,"twenty":-7.769895,"median":-3.714409,"eighty":-2.359862,"marketCap":256882964},{"date":"2024-12-13","current":-1.040564,"twenty":-7.753827,"median":-3.659012,"eighty":-2.350461,"marketCap":212263510},{"date":"2024-12-20","current":-0.877402,"twenty":-7.748728,"median":-3.626782,"eighty":-2.335862,"marketCap":178980413},{"date":"2024-12-27","current":-0.889311,"twenty":-7.730167,"median":-3.608319,"eighty":-2.323428,"marketCap":181409632},{"date":"2025-01-03","current":-0.882877,"twenty":-7.704989,"median":-3.557707,"eighty":-2.2786,"marketCap":180097296},{"date":"2025-01-10","current":-0.933392,"twenty":-7.704643,"median":-3.503182,"eighty":-2.26338,"marketCap":190401751},{"date":"2025-01-17","current":-0.80048,"twenty":-7.694621,"median":-3.473214,"eighty":-2.228646,"marketCap":163289149},{"date":"2025-01-24","current":-0.836716,"twenty":-7.674536,"median":-3.466811,"eighty":-2.211961,"marketCap":170680839},{"date":"2025-01-31","current":-0.835284,"twenty":-7.664509,"median":-3.457401,"eighty":-2.190367,"marketCap":170388677},{"date":"2025-02-07","current":-0.846455,"twenty":-7.663257,"median":-3.446877,"eighty":-2.138425,"marketCap":172667538},{"date":"2025-02-14","current":-0.833565,"twenty":-7.64653,"median":-3.402521,"eighty":-2.079975,"marketCap":170038083},{"date":"2025-02-21","current":-0.94528,"twenty":-7.642348,"median":-3.38156,"eighty":-2.054451,"marketCap":192826692},{"date":"2025-02-28","current":-1.020902,"twenty":-7.637571,"median":-3.343701,"eighty":-1.975864,"marketCap":208252828},{"date":"2025-03-07","current":-1.040381,"twenty":-7.627362,"median":-3.298717,"eighty":-1.933206,"marketCap":212226226},{"date":"2025-03-14","current":-0.521867,"twenty":-7.609389,"median":-3.265577,"eighty":-1.89885,"marketCap":178997262},{"date":"2025-03-21","current":-0.459033,"twenty":-7.587984,"median":-3.241666,"eighty":-1.893187,"marketCap":157445555},{"date":"2025-03-28","current":-0.510936,"twenty":-7.570327,"median":-3.226697,"eighty":-1.876412,"marketCap":175247856},{"date":"2025-04-04","current":-0.400244,"twenty":-7.557107,"median":-3.21693,"eighty":-1.854621,"marketCap":137281423},{"date":"2025-04-11","current":-0.357121,"twenty":-7.549923,"median":-3.198363,"eighty":-1.833647,"marketCap":122490457},{"date":"2025-04-17","current":-0.377865,"twenty":-7.53571,"median":-3.1819,"eighty":-1.804679,"marketCap":129605473},{"date":"2025-04-25","current":-0.401966,"twenty":-7.516892,"median":-3.166597,"eighty":-1.777639,"marketCap":137871881},{"date":"2025-05-02","current":-0.404697,"twenty":-7.507686,"median":-3.164484,"eighty":-1.775075,"marketCap":138808651},{"date":"2025-05-09","current":-0.368533,"twenty":-7.490537,"median":-3.162234,"eighty":-1.765463,"marketCap":126404474},{"date":"2025-05-16","current":-0.354647,"twenty":-7.4795,"median":-3.154836,"eighty":-1.754194,"marketCap":118637096},{"date":"2025-05-23","current":-0.372922,"twenty":-7.470459,"median":-3.154836,"eighty":-1.730229,"marketCap":124750584},{"date":"2025-05-30","current":-0.355548,"twenty":-7.461092,"median":-3.125893,"eighty":-1.710392,"marketCap":118938486},{"date":"2025-06-06","current":-0.507293,"twenty":-7.420321,"median":-3.116245,"eighty":-1.685899,"marketCap":169700573},{"date":"2025-06-13","current":-0.431155,"twenty":-7.403982,"median":-3.113599,"eighty":-1.670898,"marketCap":144230679},{"date":"2025-06-20","current":-0.424072,"twenty":-7.391436,"median":-3.092676,"eighty":-1.665525,"marketCap":141861387},{"date":"2025-06-27","current":-0.403709,"twenty":-7.391436,"median":-3.084406,"eighty":-1.652405,"marketCap":135049671},{"date":"2025-07-03","current":-0.428941,"twenty":-7.389083,"median":-3.074,"eighty":-1.61891,"marketCap":143490275},{"date":"2025-07-11","current":-0.432483,"twenty":-7.365757,"median":-3.059181,"eighty":-1.558478,"marketCap":144674922},{"date":"2025-07-18","current":-0.421416,"twenty":-7.354708,"median":-3.044181,"eighty":-1.530473,"marketCap":140972902},{"date":"2025-07-25","current":-0.460813,"twenty":-7.344,"median":-3.026095,"eighty":-1.517452,"marketCap":154152091},{"date":"2025-08-01","current":-0.523591,"twenty":-7.306207,"median":-3.009843,"eighty":-1.505683,"marketCap":175152551}],"updateTime":1754131861355}}}